Is hormone therapy safe? What the evidence says
For most healthy women under 60 or within ten years of menopause, the benefits of hormone therapy outweigh the risks. Here is what the major trials and current guidelines say — and what they do not.
Yes: for most healthy women under 60 or within 10 years of menopause, benefits outweigh risks, per The Menopause Society and ACOG. Hormone therapy is neither the danger many women were told two decades ago nor a risk-free wellness product — it is medicine, with real benefits and manageable risks, individualized by dose, route, and duration.
Where did the fear of hormone therapy come from?
Much of the lingering anxiety traces to early headlines from the Women's Health Initiative (WHI) in 2002. The study's average participant was 63 — well past the typical age of menopause — and the most-publicized arm used oral conjugated estrogens with a synthetic progestin. Later re-analysis showed that the risk picture is very different for women who begin therapy near the onset of menopause, which is when most women actually seek treatment.
For healthy women younger than 60 or within 10 years of menopause onset, the benefits of hormone therapy generally outweigh the risks for treating bothersome vasomotor symptoms and preventing bone loss.
What does hormone therapy treat well?
Estradiol is the most effective treatment available for hot flashes and night sweats, and it reliably improves the sleep disruption and quality-of-life burden that follow them. For women with a uterus, estradiol is paired with progesterone to protect the uterine lining. We lead with these body-identical hormones because the evidence base behind them is the strongest in the field.
- Vasomotor symptoms — hot flashes and night sweats — respond better to estrogen than to any non-hormonal option.
- Genitourinary symptoms respond to low-dose vaginal estrogen, which acts locally with minimal systemic absorption.
- Estrogen also helps preserve bone density, reducing fracture risk during the years of fastest bone loss.
What are the actual risks?
Hormone therapy is not appropriate for everyone. Absolute risks for an individual healthy woman starting near menopause are small, but they are not zero, and they depend on the formulation and route. Transdermal estradiol — a patch or gel — appears to carry a lower clot risk than oral estrogen because it bypasses first-pass liver metabolism. A clinician weighs your personal and family history before prescribing.
The decision to use hormone therapy should be individualized, weighing a woman's symptom burden against her personal risk profile, with the lowest effective dose for her treatment goals.
| Route | How it's taken | Relative VTE risk signal |
|---|---|---|
| Transdermal (patch/gel) | Applied to skin, absorbed directly into bloodstream | Appears lower — bypasses liver first-pass |
| Oral (pill) | Swallowed, processed by the liver first | Reference risk in most studies |
| Vaginal (low-dose) | Local cream, insert, or ring | Minimal systemic absorption; different risk category |
So, what's the bottom line?
For the right candidate — a healthy woman with bothersome symptoms, near the onset of menopause — hormone therapy is a well-evidenced, guideline-concordant choice. It is not a guarantee of any specific outcome, and it is not for women with certain histories. Route matters too: see how transdermal and oral estrogen compare. The point is not to talk anyone into or out of it, but to replace fear with an individualized, clinician-led decision grounded in the current evidence. If you're getting ready to have that conversation, here's how to talk to your clinician about hormone therapy.
Questions, answered
For most healthy women under 60 or within 10 years of menopause, the benefits of hormone therapy outweigh the risks. That is the position of The Menopause Society and ACOG. It still carries risks, so a licensed clinician reviews your full history before prescribing.
Explore the related treatments
If this is relevant to you, these are the treatments it most often connects to.
Hot flashes & night sweats
Hot flashes and night sweats are the most common — and most treatable — symptoms of menopause. Hormone therapy is the most effective treatment available.
See the treatmentSleep disruption
Menopause disrupts sleep through night sweats, anxiety, and falling progesterone. Treating the hormonal cause restores rest in a way sleep aids cannot.
See the treatmentMood & brain fog
Brain fog, irritability, and low mood are real, hormone-driven symptoms of the menopause transition — not personal failings.
See the treatmentMore from the science hub
Bioidentical vs compounded hormones, explained
“Bioidentical” is a marketing word, not a safety claim. Estradiol and progesterone manufactured to a tested, standardized product are body-identical and rigorously tested. Here is how to tell the categories apart — and where compounding has a legitimate, narrow role.
6 min readTransdermal vs oral estrogen: the mechanism and the evidence
Estradiol can be delivered through the skin or swallowed as a pill — and the difference is not cosmetic. Transdermal routes bypass the liver's first pass, which appears to lower clot risk. Here is the mechanism and the evidence behind that difference.
7 min readEstrogen, bone loss, and fracture risk in menopause
Estrogen helps keep bone strong, and its decline drives the fastest bone loss of a woman's life in the years around menopause. Hormone therapy is an established option to prevent that loss — within an individualized, risk-aware decision.
7 min readFeel like yourself again.
Take the 3-minute assessment, then meet your clinician by video or phone. No obligation.